切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2023, Vol. 09 ›› Issue (01) : 51 -53. doi: 10.3877/cma.j.issn.2095-9141.2023.01.010

综述

鞍区室管膜瘤的诊疗进展
何佳伟1, 张良1, 杨骐2, 高承天1, 王占祥1,()   
  1. 1. 361102 厦门,厦门大学附属第一医院神经外科
    2. 471003 洛阳,河南科技大学第一附属医院急诊科
  • 收稿日期:2022-03-09 出版日期:2023-02-15
  • 通信作者: 王占祥

Progress of diagnosis and treatment of sellar ependymoma

Jiawei He1, Liang Zhang1, Qi Yang2, Chengtian Gao1, Zhanxiang Wang1,()   

  1. 1. Department of Neurosurgery, the First Affiliated Hospital of Xiamen University, Xiamen 361102, China
    2. Department of Emergency, the First Affiliated Hospital of He'nan University of Science and Technology, Luoyang 471003, China
  • Received:2022-03-09 Published:2023-02-15
  • Corresponding author: Zhanxiang Wang
  • Supported by:
    National Natural Science Foundation of China(82072777); Key Medical and Health Projects in Xiamen(3502Z20209005)
引用本文:

何佳伟, 张良, 杨骐, 高承天, 王占祥. 鞍区室管膜瘤的诊疗进展[J]. 中华神经创伤外科电子杂志, 2023, 09(01): 51-53.

Jiawei He, Liang Zhang, Qi Yang, Chengtian Gao, Zhanxiang Wang. Progress of diagnosis and treatment of sellar ependymoma[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(01): 51-53.

鞍区室管膜瘤(SEP)是一种极其罕见的实体肿瘤,病例报道不多见。临床表现和影像学特征类似于无功能垂体腺瘤,确诊主要依赖术后组织病理学,目前尚无临床治疗指南,治疗方法以手术为主。本文结合相关文献对SEP的病因、发病机制、临床表现、诊断及治疗展开综述,以便更好地指导临床工作。

Sellar ependymoma (SEP) is an extremely rare solid tumor with few case reports. The clinical manifestations and imaging features are similar to non-functional pituitary adenomas. The diagnosis mainly depends on postoperative histopathology. Currently, there are no clinical treatment guidelines, and the treatment method is mainly surgery. This article mainly reviews the etiology, pathogenesis, clinical manifestations, diagnosis, and treatment of SEP based on the current related literature in order to better guide the clinical work.

[1]
Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016[J]. Neuro Oncol, 2019, 21(Suppl 5): v1-v100. DOI: 10.1093/neuonc/noz150.
[2]
Whipple SG, Savardekar AR, Rao S, et al. Primary tumors of the posterior pituitary gland: a systematic review of the literature in light of the new 2017 World Health Organization classification of pituitary tumors[J]. World Neurosurg, 2021, 145: 148-158. DOI: 10.1016/j.wneu.2020.09.023.
[3]
Shibuya M. Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors[J]. Brain Tumor Pathol, 2018, 35(2): 62-70. DOI: 10.1007/s10014-018-0311-6.
[4]
Zhao L, Jiang Y, Wang Y, et al. Case report: sellar ependymomas: a clinic-pathological study and literature review[J]. Front Endocrinol (Lausanne), 2021, 12: 551493. DOI: 10.3389/fendo.2021.551493.
[5]
Wang S, Zong W, Li Y, et al. Pituitary ependymoma: a case report and review of the literature[J]. World Neurosurg, 2018, 110: 43-54. DOI: 10.1016/j.wneu.2017.10.134.
[6]
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007, 114(2): 97-109. DOI: 10.1007/s00401-007-0243-4.
[7]
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary[J]. Neuro Oncol, 2021, 23(8): 1231-1251. DOI: 10.1093/neuonc/noab106.
[8]
Van Gompel JJ, Koeller KK, Meyer FB, et al. Cortical ependymoma: an unusual epileptogenic lesion[J]. J Neurosurg, 2011, 114(4): 1187-1194. DOI: 10.3171/2010.12.JNS10846.
[9]
Sarkisian SS, Schultz AL. Pituitary ependymoma[J]. U S Armed Forces Med J, 1956, 7(12): 1813-1816.
[10]
Takei Y, Seyama S, Pearl GS, et al. Ultrastructural study of the human neurohypophysis. II. Cellular elements of neural parenchyma, the pituicytes[J]. Cell Tissue Res, 1980, 205(2): 273-287. DOI: 10.1007/BF00234685.
[11]
Scheithauer BW, Swearingen B, Whyte ET, et al. Ependymoma of the sella turcica: a variant of pituicytoma[J]. Hum Pathol, 2009, 40(3): 435-40. DOI: 10.1016/j.humpath.2008.08.013.
[12]
McGuire CS, Sainani KL, Fisher PG. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study[J]. J Neurosurg, 2009, 110(4): 725-729. DOI: 10.3171/2008.9.JNS08117.
[13]
Parish JM, Bonnin JM, Goodman JM, et al. Intrasellar ependymoma: clinical, imaging, pathological, and surgical findings[J]. J Clin Neurosci, 2015, 22(4): 638-641. DOI: 10.1016/j.jocn.2014.10.026.
[14]
Asa SL, Mete O. What's new in pituitary pathology?[J]. Histopathology, 2018, 72(1): 133-141. DOI: 10.1111/his.13295.
[15]
Kumar PV. Nuclear grooves in ependymoma. Cytologic study of 21 cases[J]. Acta Cytol, 1997, 41(6): 1726-1731. DOI: 10.1159/000333176.
[16]
Belcher R, Chahal HS, Evanson J, et al. Recurrent pituitary ependymoma: a complex clinical problem[J]. Pituitary, 2010, 13(2): 176-182. DOI: 10.1007/s11102-008-0139-x.
[17]
Lee JS, Cho KH, Hong EK, et al. Pituitary ependymoma, 10-year follow-up after partial resection and radiation therapy[J]. Brain Tumor Res Treat, 2017, 5(2): 94-98. DOI: 10.14791/btrt.2017.5.2.94.
[18]
Guerrero-Pérez F, Marengo AP, Vidal N, et al. Primary tumors of the posterior pituitary: a systematic review[J]. Rev Endocr Metab Disord, 2019, 20(2): 219-238. DOI: 10.1007/s11154-019-09484-1.
[19]
Mukhida K, Asa S, Gentili F, et al. Ependymoma of the pituitary fossa. Case report and review of the literature[J]. J Neurosurg, 2006, 105(4): 616-620. DOI: 10.3171/jns.2006.105.4.616.
[20]
刘梦琦,刘有,陈志晔.鞍区室管膜瘤一例[J].中国医学科学院学报, 2019, 41(1): 139-142. DOI: 10.3881/j.issn.1000-503X.10397.
[21]
Thomson S, Chakrabarty A, Marks P. Ependymoma of the neurohypophysis[J]. Br J Neurosurg, 2001, 15(3): 277-278. DOI: 10.1080/026886901750353764.
[22]
Brat DJ, Scheithauer BW, Staugaitis SM, et al. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis[J]. Am J Surg Pathol, 2000, 24(3): 362-368. DOI: 10.1097/00000478-200003000-00004.
[23]
Lukashova-v Zangen I, Kneitz S, Monoranu CM, et al. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival[J]. Acta Neuropathol, 2007, 113(3): 325-337. DOI: 10.1007/s00401-006-0190-5.
[24]
Valassi E, Biller BM, Klibanski A, et al. Clinical features of nonpituitary sellar lesions in a large surgical series[J]. Clin Endocrinol (Oxf), 2010, 73(6): 798-807. DOI: 10.1111/j.1365-2265.2010.03881.x.
[25]
赵冬梅,黄新文,梁爽.鞍区室管膜瘤一例[J].中华放射学杂志, 2010, 44(8): 895. DOI: 10.3760/cma.j.issn.1005-1201.2010.08.028.
[26]
Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure[J]. Am J Clin Oncol, 2002, 25(2): 117-122. DOI: 10.1097/00000421-200204000-00003.
[27]
Cole TS, Potla S, Sarris CE, et al. Rare thyroid transcription factor 1-positive tumors of the sellar region: Barrow neurological institute retrospective case series[J]. World Neurosurg, 2019, 129: e294-e302. DOI: 10.1016/j.wneu.2019.05.132.
[28]
Nagata Y, Inoshita N, Fukuhara N, et al. Low-grade glioma of the neurohypophysis: clinical characteristics and surgical outcomes[J]. World Neurosurg, 2018, 114: e1225-e1231. DOI: 10.1016/j.wneu.2018.03.180.
[29]
Yoshida K, Toda M, Akiyama T, et al. Combined endoscopic endonasal and video-microscopic transcranial approach with preoperative embolization for a posterior pituitary tumor[J]. World Neurosurg, 2018, 119: 201-208. DOI: 10.1016/j.wneu.2018.07.245.
[30]
Guerrero-Pérez F, Vidal N, Marengo AP, et al. Posterior pituitary tumours: the spectrum of a unique entity. A clinical and histological study of a large case series[J]. Endocrine, 2019, 63(1): 36-43. DOI: 10.1007/s12020-018-1774-2.
[31]
Lefevre E, Bouazza S, Bielle F, et al. Management of pituicytomas: a multicenter series of eight cases[J]. Pituitary, 2018, 21(5): 507-514. DOI: 10.1007/s11102-018-0905-3.
[32]
Zhang Y, Teng Y, Zhu H, et al. Granular cell tumor of the neurohypophysis: 3 cases and a systematic literature review of 98 cases[J]. World Neurosurg, 2018, 118: e621-e630. DOI: 10.1016/j.wneu.2018.07.004.
[33]
Mack SC, Witt H, Piro RM, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy[J]. Nature, 2014, 506(7489): 445-450. DOI: 10.1038/nature13108.
[34]
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820. DOI: 10.1007/s00401-016-1545-1.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 蒋佳纯, 王晓冰, 陈培荣, 许世豪. 血清学指标联合常规超声及超声造影评分诊断原发性干燥综合征的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 622-630.
[3] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[4] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[5] 冯雪园, 韩萌萌, 马宁. 乳腺原发上皮样血管内皮瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 378-380.
[6] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[7] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[8] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[9] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[10] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[11] 吴凤芸, 滕鑫, 刘连娟. 高帧频超声造影与增强磁共振对不同直径原发性高分化肝细胞癌的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 404-408.
[12] 孙欣欣, 刘军, 陈超伍, 孙超. 超声内镜引导细针穿刺抽吸术在胰腺占位性病变中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 418-421.
[13] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[14] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[15] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
阅读次数
全文


摘要